{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:15:35Z","timestamp":1789193735000,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.jneuroim.2021.577604","type":"journal-article","created":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T02:53:20Z","timestamp":1620356000000},"page":"577604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Rescue immunoadsorption treatment for neuromyelitis optica spectrum disorder attacks unresponsive to intravenous methylprednisolone"],"prefix":"10.1016","volume":"356","author":[{"given":"Rui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangfu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muyang","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuge","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boguang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2021.577604_bb0005","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/1352458515581438","article-title":"Treatment of acute relapses in neuromyelitis optica: steroids alone versus steroids plus plasma exchange","volume":"22","author":"Abboud","year":"2016","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2021.577604_bb0010","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jneuroim.2008.05.026","article-title":"Effect of IgG immunoadsorption on serum cytokines in MG and LEMS patients","volume":"201","author":"Baggi","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2021.577604_bb0015","first-page":"787630","article-title":"Plasma exchange in severe attacks of neuromyelitis optica","volume":"2012","author":"Bonnan","year":"2012","journal-title":"Mult. Scler. Int."},{"key":"10.1016\/j.jneuroim.2021.577604_bb0020","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1177\/1352458508100837","article-title":"Plasma exchange in severe spinal attacks associated with neuromyelitis optica spectrum disorder","volume":"15","author":"Bonnan","year":"2009","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2021.577604_bb0025","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/jnnp-2017-316286","article-title":"Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders","volume":"89","author":"Bonnan","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2021.577604_bb0030","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1046\/j.1526-0968.1999.00155.x","article-title":"Immunoadsorption as a tool for the immunomodulation of the humoral and cellular immune system in autoimmune disease","volume":"3","author":"Braun","year":"1999","journal-title":"Ther. Apher."},{"key":"10.1016\/j.jneuroim.2021.577604_bb0035","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/sji.12000","article-title":"The number of regulatory T cells correlates with hemodynamic improvement in patients with inflammatory dilated cardiomyopathy after immunoadsorption therapy","volume":"77","author":"Bulut","year":"2013","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jneuroim.2021.577604_bb0040","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.eclinm.2019.10.017","article-title":"Safety and efficacy of immunoadsorption versus plasma exchange in steroid-refractory relapse of multiple sclerosis and clinically isolated syndrome: a randomised, parallel-group, controlled trial","volume":"16","author":"Dorst","year":"2019","journal-title":"EClinicalMedicine."},{"issue":"2","key":"10.1016\/j.jneuroim.2021.577604_bb1045","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1212\/NXI.0000000000000207","article-title":"Immunoadsorption therapy in autoimmune encephalitides","volume":"3","author":"Dogan Onugoren","year":"2016","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.jneuroim.2021.577604_bb0045","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1080\/14712598.2020.1749259","article-title":"Current and emerging biologics for the treatment of neuromyelitis optica spectrum disorders","volume":"20","author":"Duchow","year":"2020","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.jneuroim.2021.577604_bb0050","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1177\/1756285616646332","article-title":"Immunoadsorption in patients with neuromyelitis optica spectrum disorder","volume":"9","author":"Faissner","year":"2016","journal-title":"Ther. Adv. Neurol. Disord."},{"issue":"3","key":"10.1016\/j.jneuroim.2021.577604_bb0055","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/WCO.0000000000000694","article-title":"Neuromyelitis optica spectrum disorders: still evolving and broadening","volume":"32","author":"Fujihara","year":"2019","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.jneuroim.2021.577604_bb0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000505231","article-title":"Two cases of very-late-onset neuromyelitis optica spectrum disorder (NMOSD) in patients over the age of 80","volume":"12","author":"Fujiwara","year":"2020","journal-title":"Case. Rep. Neurol."},{"key":"10.1016\/j.jneuroim.2021.577604_bb0065","doi-asserted-by":"crossref","DOI":"10.1177\/1756286418774973","article-title":"Tryptophan immunoadsorption during pregnancy and breastfeeding in patients with acute relapse of multiple sclerosis and neuromyelitis optica","volume":"11","author":"Hoffmann","year":"2018","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.jneuroim.2021.577604_bb0070","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1055\/s-0036-1578797","article-title":"Plasma exchange and immunoadsorption in pediatric inflammatory optic neuropathy resistant to corticosteroid therapy: four French cases","volume":"47","author":"Jacquet","year":"2016","journal-title":"Neuropediatrics."},{"key":"10.1016\/j.jneuroim.2021.577604_bb0075","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.clinthera.2018.03.007","article-title":"Plasma exchange for neuromyelitis optica spectrum disorders in Chinese patients and factors predictive of short-term outcome","volume":"40","author":"Jiao","year":"2018","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jneuroim.2021.577604_bb0080","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1212\/WNL.58.1.143","article-title":"Plasma exchange for severe attacks of CNS demyelination: predictors of response","volume":"58","author":"Keegan","year":"2002","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2021.577604_bb0085","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.msard.2012.06.002","article-title":"Treatment of neuromyelitis optica: review and recommendations","volume":"1","author":"Kimbrough","year":"2012","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jneuroim.2021.577604_bb0090","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/ana.24554","article-title":"Neuromyelitis optica: evaluation of 871 attacks and 1,153 treatment courses","volume":"79","author":"Kleiter","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2021.577604_bb0095","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000504","article-title":"Apheresis therapies for NMOSD attacks: a retrospective study of 207 therapeutic interventions","volume":"5","author":"Kleiter","year":"2018","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2021.577604_bb0100","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/jca.21324","article-title":"Immunoadsorption therapy for neuromyelitis optica spectrum disorders long after the acute phase","volume":"30","author":"Kobayashi","year":"2015","journal-title":"J. Clin. Apher."},{"key":"10.1016\/j.jneuroim.2021.577604_bb0105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5692\/clinicalneurol.55.41","article-title":"Successful treatment of neuromyelitis optica spectrum disorder by early initiation of plasma exchange","volume":"55","author":"Koda","year":"2015","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.jneuroim.2021.577604_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.101480","article-title":"HA280 immunoadsorption, an alternative treatment for neuromyelitis optica spectrum disorders?","volume":"37","author":"Liu","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.jneuroim.2021.577604_bb0115","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1212\/WNL.0b013e3181b879be","article-title":"Plasma exchange for acute attacks of CNS demyelination: predictors of improvement at 6 months","volume":"73","author":"Llufriu","year":"2009","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2021.577604_bb0120","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/archophthalmol.2012.1126","article-title":"Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica","volume":"130","author":"Merle","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jneuroim.2021.577604_bb0125","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s10047-018-1044-3","article-title":"Immunoadsorption plasmapheresis treatment for the recurrent exacerbation of neuromyelitis optica spectrum disorder with a fluctuating anti-aquaporin-4 antibody level","volume":"21","author":"Nishimura","year":"2018","journal-title":"J. Artif. Organs."},{"key":"10.1016\/j.jneuroim.2021.577604_bb0130","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/1744-9987.13446","article-title":"Therapeutic plasma exchange in neuromyelitis optica spectrum disorders and related disorders in resource-limited settings: outcomes in a multiethnic single-center population","volume":"24","author":"Ong","year":"2020","journal-title":"Ther. Apher. Dial."},{"key":"10.1016\/j.jneuroim.2021.577604_bb0135","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/14737175.2020.1764352","article-title":"Moving beyond anti-aquaporin-4 antibodies: emerging biomarkers in the spectrum of neuromyelitis optica","volume":"20","author":"Rocca","year":"2020","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.jneuroim.2021.577604_bb0140","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1468-1331.2010.03066.x","article-title":"EFNS guidelines on diagnosis and management of neuromyelitis optica","volume":"17","author":"Sellner","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2021.577604_bb0145","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000572","article-title":"Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis?","volume":"6","author":"Stiebel-Kalish","year":"2019","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jneuroim.2021.577604_bb0150","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/14728222.2020.1732927","article-title":"Emerging therapeutic targets for neuromyelitis optica spectrum disorder","volume":"24","author":"Tradtrantip","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.jneuroim.2021.577604_bb0155","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.mayocp.2016.12.014","article-title":"Neuromyelitis spectrum disorders","volume":"92","author":"Weinshenker","year":"2017","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jneuroim.2021.577604_bb0160","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic\u2019s syndrome)","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2021.577604_bb0165","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International panel for neuromyelitis optica spectrum diagnosis","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology."},{"key":"10.1016\/j.jneuroim.2021.577604_bb0170","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/1744-9987.12347","article-title":"Efficacy of tryptophan immunoadsorption plasmapheresis for neuromyelitis optica in two cases","volume":"19","author":"Yasuda","year":"2015","journal-title":"Ther. Apher. Dial."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572821001314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572821001314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:39:45Z","timestamp":1759048785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572821001314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":35,"alternative-id":["S0165572821001314"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577604","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rescue immunoadsorption treatment for neuromyelitis optica spectrum disorder attacks unresponsive to intravenous methylprednisolone","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577604","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"577604"}}